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ABSTRACT 
Objective: This study aims to determine the effect of the inclusion complex formation of ibuprofen (IB) with β-cyclodextrin (β-CD) in improving 
water solubility and taste masking as well as to study the effect of the combined use of super disintegrants in IB-β-CD ODT (Orally disintegrating 
tablet). 
Methods: IB-β-CD inclusion complex was prepared by spray drying technique with a 1:1 molar ratio. ODTs were prepared by the direct 
compression method using various ratios of Ac-Di-Sol® and Kollidon® CL as super disintegrant. The inclusion complex was characterized using 
spectroscopy FT-IR (Fourier-transform infrared) and DSC (Differential Scanning Calorimetry). The physical properties and dissolution rate of ODTs 
were evaluated. Dissolved drug concentration at 60 min (Q60) and Dissolution Efficiency (DE60
Results: The unpleasant taste of IB had been successfully masked by IB-β-CD. Formula 1 was observed having 14.5 sec of disintegration, fastest 
compared to the other formulas. Moreover DE
) was calculated using the dissolution test result.  
60 
Conclusion: IB-β-CD Inclusion complex prepared by spray drying method (1: 1) increased the water solubility and masked the unpleasant 
taste compared to IB moreover combination of Ac-Di-Sol® and Kollidon® CL increased ODT dissolution rate. 
value of formula I was higher than the other formulas (113.45). 
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INTRODUCTION 
Ibuprofen (IB) is an NSAID (Nonsteroidal Anti-Inflammatory Drug) 
that belongs to the propionic acid derivative. IB mechanism of action 
is inhibition of cyclooxygenase-1 and cyclooxygenase-2 isoenzymes 
by interfering synthesis of prostaglandin from arachidonic acid, 
whereas prostaglandins are messenger molecules in inflammatory 
processes [1]. According to the Biopharmaceutics Classification 
System, IB is a BCS class II drug, which has poor solubility but good 
permeability properties [2]. Thus, IB absorption is limited by its 
poor water solubility. This can hamper its oral bioavailability and 
onset of action. Several approached have been employed to increase 
IB water solubility and oral bioavailability, such as solid dispersion 
[3], size reduction [4], copolymer [5], and surfactant [6]. Inclusion 
complex, especially using cyclodextrin (CD), has been widely used to 
increase the water solubility of poorly water-soluble drugs as well as 
enhance bioavailability [7].  
CDs are cyclic oligosaccharide which has a hydrophilic outer surface 
and lipophilic surface in the central cavity. The lipophilic cavity of 
CD is capable to house lipophilic drugs via a non-covalent bond. 
Thus, hindering the lipophilic surface of a drug to directly contact 
with water leaving only CD hydrophilic surface resulting in an 
increased in water solubility. β-CD is one of the CD family which 
contains seven-unit of glucose. β-CD has several advantages such as 
efficient drug loading and complexing mechanism, readily available, 
and relatively low-cost [8]. Solubility improvement by using 
inclusion complex with CD has many advantages compared to the 
other approach, such as improving drug stability, prevent 
incompatibility during formulation, reduce risk of gastric irritation 
and odor, as well as taste masking [9].  
IB is a widely used analgesic in children and elderly [10, 11]. 
Children and elderly commonly have swallowing difficulties. 
This may result in decreased patient compliance and minimize 
treatment effectiveness [12]. One of the approaches to increase 
patient acceptance toward orally solid dosage form is an orally 
disintegrating tablet (ODT). ODT is rapidly dissolved tablet with 
a small amount of saliva within seconds when placed on the 
tongue. This is suitable for people with swallowing difficulties. 
Moreover, ODTs can give rapid onset of action, improve 
bioavailability due to rapid dissolution and pre-gastric 
absorption, which reduced the number of drugs that undergo 
first-pass metabolism [13]. 
In order to achieve rapid dissolution time, the combination of super 
disintegrants could be used. Superdisintegrant is a disintegrant that 
has been modified to produce a disintegrant that is able to 
disintegrate rapidly [14]. A Combination of super disintegrant is 
expected to increase the disintegration rate and dissolution rate of 
the tablet. Superdisintegrants used in this study were Ac-Di-Sol and 
Kollidon Cl. The formation of IB-β-CD inclusion complex and the 
incorporation of superdisintegrant mechanism of Ac-Di-Sol and 
Kollidon Cl are expected to increase solubility, dissolution, and mask 
the unpleasant taste of IB. Thus, this study aims to determine the 
effect of the inclusion complex formation of IB with β-CD in 
improving water solubility and taste masking as well as to 
study the effect of the combined use of super disintegrants in IB-β-
CD ODT (Orally disintegrating tablet). 
MATERIALS AND METHODS 
Materials 
The materials used in this study were ibuprofen, β-cyclodextrin, 
Ac-Di-Sol®
Apparatus 
, Kollidon CL, Avicel PH 102, aspartame, magnesium 
stearate, talc, phosphate buffer pH 7.2, methylene blue, water, 
methanol p. a., dan ethanol 96%. Distilled water, methanol p.a 
(pro-analysis), and 96% ethanol. All materials used in this study had a 
quality for pharmaceutical use (Pharmaceutical grade) and analysis 
(pro analysis). 
The apparatus used for this study were tableting machine (Single 
Punch Korsch), hardness tester (Stokes Mosanto), UV/Visible (Hitachi 
U-2810), analytical balance (Mettler Toledo), disintegration tester 
(Erweka), friabilator abrasive tester (Erweka type TAP, 
Germany) dissolution test apparatus (USP type II), spray dryer, FT-
IR spectrophotometry and DSC instrument. 
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Preparation IB-β-CD inclusion complex 
IB and β-CD with a mole ratio of 1: 1 were weighted. β-CD was 
dissolved in distilled water at a temperature of 20-25 °C in a 
beaker glass, then stirred until a homogeneous mixture was 
formed. IB, which had been wetted with methanol then it was 
mixed into β-CD solution with constant stirring until the 
suspension was formed. The suspension was then spray 
dried with a temperature of 120 °C. The yield was then weighed to 
get a solid mass [15–17]. 
Characterization results of inclusion complexes with FT-IR  
2-3 mg of sample was mixed with 400 mg dry KBr then pressed in 
a transparent disk under the pressure of 10000-15000 psi. IR 
spectra were recorded in the range of 500-4000 cm-1 with a 
resolution of 4 cm-1
ODTs were made by the direct compression method after IB-β-CD 
inclusion complex had been prepared [21]. Avicel PH 102 was used 
as a filler binder. Superdisintegrant used were Ac-Di-Sol and 
Kollidon Cl with various concentrations, magnesium stearate-
talk (lubricant), and aspartame as the sweetener agent. The 
homogeneous mixture of ingredients was compressed with a single 
punch tableting machine, and the size of the upper and lower punch 
was set to obtain tablets with 400 mg weight and hardness of 3-5 
kg. The composition of each IB ODT formula can be seen in table 1. 
 [18, 19]. 
Characterization results of inclusion complexes with DSC  
A sample of 5 mg was spread over the aluminum pan and heated in a 
DSC instrument in the nitrogenous room. The heating rate was 
regulated at 5 °C/min in a temperature range of 25-500 °C [20]. 
Thermogram was then recorded. 
ODT manufacture  
Evaluation of physical properties of the tablet 
Weight uniformity study was conducted on twenty tablets taken 
randomly from each formula. The tablets were weighed one by one 
with an analytical balance. Mean and coefficient of variation (CV) 
were calculated from weighing results. 
The hardness test was done by taking 6 tablets from each 
formula. The values of the hardness were obtained and then the 
mean was calculated. 
Tablet friability study was done by taking twenty tablets of each 
formulation and cleaned from dust and weighed. The tablets were 
then put into friability tester and was ran at 25 rpm for 4 
min. Tablets were cleaned from dust and weighed again as final 
weights, then the friability of the tablet was calculated. 
Tablet disintegration and wetting time study 
ODT disintegration time test was done by placing a tablet on a 5-
cm diameter petri dish containing phosphate buffer pH 7.2 of 20 
ml. The disintegration time required by 6 tablets were recorded 
and then the mean were calculated [22]. The filter paper was 
folded twice and placed on a petri dish (5 cm diameter) filled with 
5 ml of distilled water containing methylene blue. One tablet was 
then placed gently on the filter paper. The time required to 
generate a blue color on the entire surface of the tablet was 
calculated as the wetting time [22]. 
 
Table 1: Formula ODT Ibuprofen 
Composition Formula I. Formula II Formula III Formula IV Formula V 
Inclusion complex 322.4 322.4 322.4 322.4 322.4 
Ac-Di-Sol 5 7.5 10 12.5 15 
Kollidon Cl 15 12.5 10 7.5 5 
Avicel pH 102 51.6 51.6 51.6 51.6 51.6 
Aspartame 4 4 4 4 4 
Mg stearate 0.2 0.2 0.2 0.2 0.2 
Talc 1.8 1.8 1.8 1.8 1.8 
Total (mg) 400 400 400 400 400 
  
Tablet dissolution study 
This test was done by putting ODT into the dissolution medium of 
900 ml phosphate buffer pH 7.2 using USP apparatus type II with a 
rotation speed of 50 rpm with a temperature of 37±0.5 °C. The 
samples were withdrawn at 1, 3, 5, 10, 15, 20, 30, and 60 min by 
taking 5.0 ml of the medium (5.0 ml fresh medium was added on 
each sampling to keep the volume constant). The absorbance was 
measured at a wavelength of 264 nm and percentage of drug 
released was calculated [23]. 
RESULTS AND DISCUSSION 
Examination of organoleptic  
The organoleptic test was conducted to describe the color and taste 
of pure IB powder and IB-β-CD. Organoleptic test results were 
shown in table 2. According to table 2 that the spray 
drying method had undergone an inclusion complex in which 
inclusion complex results were ranging from tasteless to sweet 
which successfully masked its original bitter taste. This agrees with 
several studies that reported that CD inclusion complexes possessed 
taste-masking properties [24, 25]. Taste masking was the result of 
entrapment of drug molecule into CD cavity and the presence of 
sugar molecule in CD, hindered the unpleasant taste [26]. The 
resulting color was still white since both IB and β-CD 
were equally white-colored. 
Result of characterization of inclusion complex 
Infrared spectroscopy is a type of spectroscopy that is specific to a 
molecule that will provide information about the functional groups 
present in the molecule, selective to isomer because of fingerprint 
region, quantitative, nondestructive and universal. FT-IR analysis 
results can be seen in fig. 1. 
 
Table 2: Powdered ibuprofen organoleptic test results and inclusion complex results 
Organoleptic parameters IB IB-β-CD 
Physical mix Spray drying 
Color White White White 
Flavors Bitter A bit bitter No taste 
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Fig. 1: Test results Fourier-transform infrared (FTIR) spectroscopy (a) Ibuprofen, (b) β-cyclodextrin, (c) Results of inclusion complex 
 
Based on the fig. 1. IB appeared at a peak around 1720.50 cm-
1(carbonyl stretching of iso propionic acid group) and 2954.95 cm-
1and 1066.64 cm-1 regions. While on spectra of inclusion complex 
results showed no visible peaks like the pure ibuprofen, an 
only peak which was similar to that β-CD, peak which was widened 
peak at 3342.64 and 2926.01 cm-1 
Analysis with DSC can provide information about the change of 
material properties to heat with enthalpy as parameter measured. 
regions. This proved that IB had 
been incorporated into the β-CD cavity. 
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Character determination with DSC in IB, β-CD, and IB-β-CD with 
spray drying method presented in table 2. 
The thermogram of IB shown endothermic peak of 77.21 °C, 
whereas on the result of the inclusion complex the endothermic 
peak was not visible. The thermogram of inclusion complexes shown 
an endothermal peak of 125, 96 °C, where this peak was also visible 
on the β-CD thermogram.  
Thus, proved IB had successfully entered the β-CD cavity. 
 
 
Fig. 2: Test results differential scanning calorimetry (DSC) (a) Ibuprofen, (b) β-cyclodextrin, (c) Results of inclusion complexes 
 
 Evaluation of physical properties of IB ODTs 
The result of the uniformity test of all formula weights showed that 
CV value was less than 5%. The resulting ODTs hardness was at the 
accepted range, where good ODT has a range of 3-5 kg 
hardness. Friability test results indicate a value of less than 1%, 
which fulfilled the requirement. The wetting time of the ODT 
formulas showed that formula I had the fastest time compared to 
other formulas. The disintegration test of all formulas showed that 
all the tablets disintegrated within less than one minute. Formula 1 
showed the most rapid disintegration time and corresponded to the 
wetting time, where the highest proportion of Kollidon Cl would aid 
the process of water entry into the tablet, easily expanding tablets 
without rapid gel formation. Thus, the tablets would disintegrate 
rapidly. The highly porous structure of Kollidon CL would accelerate 
the disintegration rate, as water would rapidly enter the tablet and 
increase the wetting rate [27]. The result of physical properties 
evaluation can be seen in table 3. 
Dissolution test results 
The dissolution profile of the five ODT formulas, where in the first 3 
min the amount of nifedipine released was more than 50%. This 
happened because the combination of two superdisintegrants made 
the tablets disintegrate and dissolve rapidly. The three 
aforementioned formulas had more than 80% dissolved percentage 
in 60th
  
 minute. Formula 1 had the highest solubility compared to 
other formulas. Improvement in dissolution time potentially 
improved drug oral bioavailability since the rate-limiting step of the 
absorption of IB was dissolution time [28]. 
Table 3: Parameter of ODT physical characteristics 
Formula Uniformity of weights (CV %) Hardness (kg/cm Friability (%)2)* Disintegration time (sec)* Wetting time (sec)* * 
1 0.35 4.19±0.20 0.05±0.01 14.50±0.46 7.30±0.36 



















*The data are written the average value and the SD value of each formula 
 
 
Fig. 3: Dissolution profile of Ibuprofen ODT 
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Table 4, showed that the DE60 value of formula I was greater than 
the other formulas. Differences in the composition of super 
disintegrant in every formula gave distinction in dissolution test 
results (DE60
CONCLUSION 
). Where the increase in the number of Ac-Di-Sol in 
each formula gave distinctive dissolution results. Ac-Di-Sol increases 
water penetration through porous surface into the tablet [29], 
resulting in rapid dissolution time. 
The formation of IB-β-CD inclusion complex using spray drying 
method (1: 1) can increase solubility and mask bitter taste 
compared to IB alone. Moreover, combination of super disintegrant 
Ac-Di-Sol and Kollidon Cl can increase ODT dissolution rate.  
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